Top Markets
Coin of the day
Dermisonics, Inc. Dermisonics, Inc.

Dermisonics, Inc.

DMSI
Rangering i aksjer #42356
Dermisonics, Inc. develops and produces ultrasonic technologies and equipment... Dermisonics, Inc. develops and produces ultrasonic technologies and equipment for the transdermal administration of medications. A core focus for the company is the creation, evaluation, and market launch of its unique active transdermal patch, known as the U-Strip. This innovative patch is designed to facilitate the needle-free entry of large molecular weight drugs, like Insulin, directly into the circulatory system. The firm was originally incorporated as Second Stage Ventures, Inc. before adopting its current name, Dermisonics, Inc., in October 2004. Founded in 2000, the company maintains its principal offices in Irvine, California.
Aksjekurs
$0.00003
Sist synkronisert: 2026-08-11
Markedsverdi
$1.92K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Dermisonics, Inc. (DMSI)

Kategori

P/S-forhold for Dermisonics, Inc. (DMSI)
P/S-forhold per 2026 TTM: 0
Ifølge Dermisonics, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Dermisonics, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter